c-Srcとc-Ablキナーゼの異なる柔軟性は,薬効性のある不活性構造のアクセシビリティを調節する
Silvia Lovera1, Ludovico Sutto, Ralitza Boubeva
1Structural Biology and Biocomputing Programme, Spanish National Cancer Research Center (CNIO), Melchor Fernandez Almagro 3, E-28029 Madrid, Spain.
Journal of the American Chemical Society
|January 28, 2012
まとめ
抗がん剤イマチニブは,タンパク質キナーゼc-Srcおよびc-Ablを標的とする. キナーゼの柔軟性の違いがイマチニブを説明する.
科学分野:
- バイオケミストリーと分子生物学
- 構造生物学 構造生物学とは
- 薬理学 薬理学とは
背景:
- c-Srcとc-Ablは密接に関連したタンパク質キナーゼであり,重要な抗がん標的である.
- これらのキナーゼは,抗がん剤イマチニブに対して異なる感受性を示す.
- イマチニブは,非活性キナーゼ構成 (DFG-out) に選択的に結合する.
研究 の 目的:
- c-Srcとc-Abl.でDFGの形状転換を調査する.
- c-Srcとc-Ablの間のイマチニブの選択性の差異の分子基礎を解明する.
主な方法:
- 広範な分子ダイナミクスシミュレーション.
- 無料エネルギーの計算.
- アイソテルミックタイトレーション熱計.
主要な成果:
- c-Srcとc-AblでDFG-inからDFG-outへの移行のための自由エネルギー表面を再構築.
- c-Srcとc-Abl.の間の明確な柔軟性プロファイルが特定されました.
- 各キナーゼのDFG-outコンフォーメーションの安定性を変化させることが実証された.
結論:
- c-Srcとc-Ablの微分柔軟性は,DFG-outの適合安定性に影響する.
- キナーゼの柔軟性は,イマチニブ選択性の重要な決定因子です.
- これらのダイナミクスを理解すると,より選択的なキナーゼ阻害剤の設計に役立ちます.
関連する概念動画
01:30Assembly of Signaling Complexes
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
00:50Anaphase Promoting Complex
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
01:19Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
00:49Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
01:57Protein Complexes with Interchangeable Parts
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...